Literature DB >> 3123492

The recognition by RNase P of precursor tRNAs.

M F Baer1, R M Reilly, G M McCorkle, T Y Hai, S Altman, U L RajBhandary.   

Abstract

We have generated mutants of M1 RNA, the catalytic subunit of Escherichia coli RNaseP, and have analyzed their properties in vitro and in vivo. The mutations, A333----C333, A334----U334, and A333 A334----C333 U334 are within the sequence UGAAU which is complementary to the GT psi CR sequence found in loop IV of all E. coli tRNAs. We have examined: 1) whether the mutant M1 RNAs are active in processing wild type tRNA precursors and 2) whether they can restore the processing defect in mutant tRNA precursors with changes within the GT psi CR sequence. As substrates for in vitro studies we used wild type E. coli SuIII tRNA(Tyr) precursor, and pTyrA54, a mutant tRNA precursor with a base change that could potentially complement the U334 mutation in M1 RNA. The C333 mutation had no effect on activity of M1 RNA on wild type pTyr. The U334 mutant M1 RNA, on the other hand, had a much lower activity on wild type pTyr. However, use of pTyrA54 as substrate instead of wild type pTyr did not restore the activity of the U334 mutant M1 RNA. These results suggest that interactions via base pairing between nucleotides 331-335 of M1 RNA and the GT psi CG of pTyr are probably not essential for cleavage of these tRNA precursors by M1 RNA. For assays of in vivo function, we examined the ability of mutant M1 RNAs to complement a ts mutation in the protein component of RNaseP in FS101, a recA- derivative of E. coli strain A49. In contrast to wild type M1 RNA, which complements the ts mutation when it is overproduced, neither the C333 nor the U334 mutant M1 RNAs was able to do so.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123492

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Determinants of Escherichia coli RNase P cleavage site selection: a detailed in vitro and in vivo analysis.

Authors:  S G Svärd; L A Kirsebom
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

2.  Different cleavage sites are aligned differently in the active site of M1 RNA, the catalytic subunit of Escherichia coli RNase P.

Authors:  J Kufel; L A Kirsebom
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Regulation of human RNA polymerase III transcription by DNMT1 and DNMT3a DNA methyltransferases.

Authors:  Tharakeswari Selvakumar; Alison Gjidoda; Stacy L Hovde; R William Henry
Journal:  J Biol Chem       Date:  2012-01-04       Impact factor: 5.157

4.  Purine N7 groups that are crucial to the interaction of Escherichia coli rnase P RNA with tRNA.

Authors:  C Heide; R Feltens; R K Hartmann
Journal:  RNA       Date:  2001-07       Impact factor: 4.942

Review 5.  Construction of bacteriophage phi29 DNA packaging motor and its applications in nanotechnology and therapy.

Authors:  Tae Jin Lee; Chad Schwartz; Peixuan Guo
Journal:  Ann Biomed Eng       Date:  2009-06-04       Impact factor: 3.934

Review 6.  Transcriptional regulation of human small nuclear RNA genes.

Authors:  Gauri W Jawdekar; R William Henry
Journal:  Biochim Biophys Acta       Date:  2008-04-08

7.  Efficient site-specific cleavage by RNase MRP requires interaction with two evolutionarily conserved mitochondrial RNA sequences.

Authors:  J L Bennett; D A Clayton
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

8.  Characterization in vitro of the defect in a temperature-sensitive mutant of the protein subunit of RNase P from Escherichia coli.

Authors:  M F Baer; D Wesolowski; S Altman
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

9.  Substrate recognition by RNase P and by the catalytic M1 RNA: identification of possible contact points in pre-tRNAs.

Authors:  D Kahle; U Wehmeyer; G Krupp
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

10.  Gene silencing in the therapy of influenza and other respiratory diseases: Targeting to RNase P by use of External Guide Sequences (EGS).

Authors:  David H Dreyfus; S Mark Tompkins; Ramsay Fuleihan; Lucy Y Ghoda
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.